See more : Sierra Lake Acquisition Corp. (SIERW) Income Statement Analysis – Financial Results
Complete financial analysis of ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. (603976.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd., a leading company in the Packaging & Containers industry within the Consumer Cyclical sector.
- Scotch Creek Ventures Inc. (SCV.CN) Income Statement Analysis – Financial Results
- AFC Ajax NV (AJAX.AS) Income Statement Analysis – Financial Results
- Guangdong Piano Customized Furniture Co., Ltd. (002853.SZ) Income Statement Analysis – Financial Results
- Jiangsu Alcha Aluminium Group Co., Ltd. (002160.SZ) Income Statement Analysis – Financial Results
- Crestwood Equity Partners LP (CEQP-P) Income Statement Analysis – Financial Results
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. (603976.SS)
About ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd.
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China. It offers medium borosilicate glass ampoule bottles, medium borosilicate glass tube injection bottles, low borosilicate tubular vials and ampoules, oral liquid vials, screw neck vials, and plastic flip off and aluminum caps, as well as borosilicate glass and soda lime glass control bottles. The company was founded in 1988 and is headquartered in Chongqing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 900.65M | 796.20M | 796.66M | 501.98M | 521.08M | 595.78M | 508.68M | 469.99M | 479.68M | 436.03M | 405.80M |
| Cost of Revenue | 759.02M | 629.41M | 592.02M | 373.72M | 379.67M | 424.98M | 347.67M | 319.85M | 349.13M | 302.79M | 290.36M |
| Gross Profit | 141.63M | 166.79M | 204.64M | 128.26M | 141.41M | 170.80M | 161.01M | 150.15M | 130.56M | 133.25M | 115.44M |
| Gross Profit Ratio | 15.72% | 20.95% | 25.69% | 25.55% | 27.14% | 28.67% | 31.65% | 31.95% | 27.22% | 30.56% | 28.45% |
| Research & Development | 23.43M | 19.11M | 12.08M | 8.25M | 5.27M | 2.90M | 31.11K | 20.78M | 24.32M | 16.31M | 0.00 |
| General & Administrative | 9.75M | 7.43M | 10.94M | 8.70M | 10.22M | 12.20M | 11.72M | 13.05M | 9.50M | 8.12M | 25.12M |
| Selling & Marketing | 13.61M | 15.13M | 17.97M | 31.31M | 33.65M | 35.91M | 30.47M | 28.06M | 25.63M | 24.59M | 26.06M |
| SG&A | 23.36M | 22.57M | 28.90M | 40.01M | 43.87M | 48.11M | 42.19M | 41.11M | 35.14M | 32.72M | 51.18M |
| Other Expenses | 49.97M | 39.86M | 34.81M | 27.44M | 32.45M | -89.00K | 218.16K | 4.43M | 2.44M | 3.43M | 1.76M |
| Operating Expenses | 96.76M | 81.54M | 75.79M | 75.71M | 81.60M | 85.73M | 65.72M | 68.45M | 61.60M | 58.05M | 54.72M |
| Cost & Expenses | 855.78M | 710.94M | 667.81M | 449.43M | 461.27M | 510.72M | 413.39M | 388.30M | 410.72M | 360.84M | 345.08M |
| Interest Income | 3.26M | 4.89M | 7.82M | 10.76M | 13.22M | 13.43M | 2.28M | 666.04K | 1.26M | 2.24M | 0.00 |
| Interest Expense | 21.30M | 19.61M | 13.08M | 289.81K | 206.51K | 81.78K | 259.79K | 87.15K | 215.93K | 757.43K | 0.00 |
| Depreciation & Amortization | 107.07M | 87.58M | 68.05M | 54.56M | 51.89M | 47.99M | 41.94M | 30.66M | 26.98M | 24.88M | -997.03K |
| EBITDA | 173.20M | 165.79M | 206.70M | 116.44M | 111.18M | 142.08M | 139.17M | 113.90M | 96.79M | 102.80M | 60.72M |
| EBITDA Ratio | 19.23% | 22.57% | 26.26% | 23.14% | 21.52% | 24.60% | 27.46% | 25.23% | 20.77% | 24.25% | 14.98% |
| Operating Income | 44.87M | 93.25M | 122.64M | 61.89M | 71.89M | 94.10M | 96.73M | 79.25M | 68.23M | 76.53M | 61.81M |
| Operating Income Ratio | 4.98% | 11.71% | 15.39% | 12.33% | 13.80% | 15.79% | 19.02% | 16.86% | 14.22% | 17.55% | 15.23% |
| Total Other Income/Expenses | -43.92K | -34.70M | 3.33M | -512.65K | -545.19K | -89.00K | 218.16K | 3.81M | 1.39M | 3.28M | 1.16M |
| Income Before Tax | 44.83M | 58.55M | 125.97M | 61.38M | 71.35M | 94.01M | 96.95M | 83.07M | 69.62M | 79.81M | 62.97M |
| Income Before Tax Ratio | 4.98% | 7.35% | 15.81% | 12.23% | 13.69% | 15.78% | 19.06% | 17.67% | 14.51% | 18.30% | 15.52% |
| Income Tax Expense | 4.56M | -6.21M | 19.37M | 8.33M | 10.29M | 11.24M | 14.77M | 12.55M | 8.92M | 10.89M | 8.23M |
| Net Income | 40.27M | 64.77M | 106.60M | 53.05M | 61.06M | 82.77M | 82.18M | 70.51M | 60.70M | 68.91M | 54.74M |
| Net Income Ratio | 4.47% | 8.13% | 13.38% | 10.57% | 11.72% | 13.89% | 16.16% | 15.00% | 12.65% | 15.80% | 13.49% |
| EPS | 0.27 | 0.43 | 0.71 | 0.35 | 0.40 | 0.55 | 0.65 | 0.62 | 0.54 | 0.61 | 0.49 |
| EPS Diluted | 0.27 | 0.43 | 0.71 | 0.35 | 0.40 | 0.55 | 0.65 | 0.62 | 0.54 | 0.61 | 0.49 |
| Weighted Avg Shares Out | 149.14M | 151.20M | 151.20M | 151.20M | 151.20M | 150.48M | 126.43M | 113.47M | 113.30M | 113.50M | 112.70M |
| Weighted Avg Shares Out (Dil) | 149.14M | 151.20M | 151.20M | 151.20M | 151.20M | 150.48M | 126.43M | 113.47M | 113.30M | 113.50M | 112.70M |
Source: https://incomestatements.info
Category: Stock Reports